| Synonyms | (2S)-3-Methyl-2-(pentanoyl-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)amino)butanoic acid
Valsartan (JP17/USAN/INN)
(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
Valsartan, United States Pharmacopeia (USP) Reference Standard
DB00177
(S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine
ZINC3875259
EZR-104
3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-yl]-amino}-butyric acid
HMS2232F05
4997-EP2298776A1
J10013
NSC758927
KS-00000ISS
s1894
AB00639940_11
LS-161334
SPBio_001260
AK-58790
N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine
SR-05000001928-1
BC204156
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine
VA11929
BSPBio_003501
Vals
CCG-221275
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
Valsartan [USAN:INN]
CS-1967
(S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
Valtan (TN)
Diovan, Valsartan
(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
GTPL3937
4997-EP2272841A1
HSDB 7519
N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine
4997-EP2301931A1
KBio2_004855
Prexxartan (oral solution)
80M03YXJ7I
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
SBI-0206738.P001
AC-4543
Miten
Spectrum3_001831
AM90287
N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
Tareg
BG0645
valsartan (Diovan)
CGP-48933
(2S)-3-Methyl-2-{N-pentanoyl-N'-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butanoic acid
Valsartan, European Pharmacopoeia (EP) Reference Standard
D06UDG
(S)-3-Methyl-2-{pentanoyl-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
Varexan
Esteve brand of valsartan
2-{[2''-(2,3-Dihydro-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid
HMS2051L12
4997-EP2295422A2
I997
Novartis brand of valsartan
4997-EP2308562A2
KBioGR_001078
RTR-031794
AB00639940-08
L-Valsartan
Schwarz brand of valsartan
ACT02671
MolPort-002-507-854
Spectrum_001796
Aventis brand of valsartan
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-L-valine
UNII-80M03YXJ7I
BRD-K45158365-001-02-3
(2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
Valsartan for peak identification, European Pharmacopoeia (EP) Reference Standard
CHEMBL1069
(s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid
Valsartan,(S)
Diovan
(S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine
[3H]valsartan
FT-0631156
HMS3651E04
4997-EP2298779A1
Kalpress
Pharmakon1600-01505209
KS-1194
SAM001246581
AB07510
MCULE-6728882368
SPECTRUM1505209
AKOS015914315
N-(1-oxopentyl)-N-[[2'-(1h-tetrazol-5-yl) [1,1'-bi-phenyl]-4-yl]methyl]-l-valine
ST2408288
BCP05184
N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
VAL-489
C24H29N5O3
Valsarran
CEPA brand of valsartan
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
Valsartan [USAN:USP:INN:BAN]
D00400
(s)-3-methyl-2-{pentanoyl-[-2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
Valzaar
DS-1248
137862-53-4
GTPL593
4997-EP2277879A1
HY-18204
NC00278
4997-EP2301936A1
KBio2_007423
Provas
AB0013966
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI)
SC-00971
AC1L1U1M
MLS000759423
Spectrum4_000749
AN-7255
N-(1-OXOPENTYL)-N-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE
TL8000869
BIDD:GT0345
Valsartan (JAN/USAN/INN)
CHEBI:9927
(5)-2-{N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]pentanamido}-3-methylbutanoic acid
Valsartan, Pharmaceutical Secondary Standard; Certified Reference Material
(S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
walsartan
Exforge
3-Methyl-2-{((S)-pentanoyl)-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
HMS2093K22
4997-EP2298772A1
J-007068
NSC-758927
4997-EP2308839A1
KBioSS_002289
S-6418
AB00639940_09
Lacer brand of valsartan
SMR000466318
ACWBQPMHZXGDFX-QFIPXVFZSA-N
MolPort-003-666-608
SR-05000001928
AX8018200
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
V-120
BRD-K45158365-001-05-6
CCG-101028
(2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
Valsartan for system suitability, European Pharmacopoeia (EP) Reference Standard
CPD000466318
(s)-3-methyl-2-[N-({4-[2-(2h-1,2,3,4-tetrazol-5-yl) phenyl]phenyl}methyl)pentanamido]butanoic acid
Valtan
Diovan (TN)
(S)-N-(1-Carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine
GP8514
4997-EP2270011A1
HMS3715P12
N-Valeryl-N-[2'-(5-tetrazolyl)biphenyl-4-ylmethyl]-L-valine
4997-EP2301923A1
KBio2_002287
Prexxartan
62V534
L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-
Sanol brand of valsartan
AB2000354
MFCD00865840
Spectrum2_001120
AKOS015994698
N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(L)-valine
SW197658-2
BDBM50049186
N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine
Valpression
CGP 48933
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid.
Valsartan, >=98% (HPLC)
D04HSR
(S)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
Valzaar (TN)
EC 604-045-2
137863-60-6
HMS1922L21
4997-EP2295406A1
I14-41498
Nisis
4997-EP2305219A1
KBio3_003006
PubChem9865
AB00639940-06
L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
SCHEMBL2542
AC1Q5QIK
MLS001424088
Spectrum5_001582
ANW-49040
N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
TR-031794
BR-58790 [ Show all ] |
|---|
| Inchi ID | InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1 |
|---|
zhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218